These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33471400)

  • 61. Regional and source-based patterns of [
    Worhunsky PD; Matuskey D; Gallezot JD; Gaiser EC; Nabulsi N; Angarita GA; Calhoun VD; Malison RT; Potenza MN; Carson RE
    Neuroimage; 2017 Mar; 148():343-351. PubMed ID: 28110088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats.
    Kilbourn MR; Domino EF
    Eur J Pharmacol; 2011 Mar; 654(3):254-7. PubMed ID: 21262223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo.
    Gallezot JD; Beaver JD; Gunn RN; Nabulsi N; Weinzimmer D; Singhal T; Slifstein M; Fowles K; Ding YS; Huang Y; Laruelle M; Carson RE; Rabiner EA
    Synapse; 2012 Jun; 66(6):489-500. PubMed ID: 22213512
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats.
    Ginovart N; Hassoun W; Le Cavorsin M; Veyre L; Le Bars D; Leviel V
    Neuropsychopharmacology; 2002 Jul; 27(1):72-84. PubMed ID: 12062908
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone.
    Sun W; Ginovart N; Ko F; Seeman P; Kapur S
    Mol Pharmacol; 2003 Feb; 63(2):456-62. PubMed ID: 12527818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum.
    Martinez D; Gil R; Slifstein M; Hwang DR; Huang Y; Perez A; Kegeles L; Talbot P; Evans S; Krystal J; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Nov; 58(10):779-86. PubMed ID: 16018986
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
    Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
    J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Separating dopamine D
    Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
    Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
    Leyton M; Dagher A; Boileau I; Casey K; Baker GB; Diksic M; Gunn R; Young SN; Benkelfat C
    Neuropsychopharmacology; 2004 Feb; 29(2):427-32. PubMed ID: 14583741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopaminergic activity in depressed smokers: a positron emission tomography study.
    Busto UE; Redden L; Mayberg H; Kapur S; Houle S; Zawertailo LA
    Synapse; 2009 Aug; 63(8):681-9. PubMed ID: 19360907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
    Felger JC; Mun J; Kimmel HL; Nye JA; Drake DF; Hernandez CR; Freeman AA; Rye DB; Goodman MM; Howell LL; Miller AH
    Neuropsychopharmacology; 2013 Oct; 38(11):2179-87. PubMed ID: 23657438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vitamin D's Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [
    Worhunsky PD; Mignosa MM; Gallezot JD; Pittman B; Nabulsi NB; Stryjewski A; Jalilian-Khave L; Trinko R; DiLeone RJ; Carson RE; Malison RT; Potenza MN; Angarita GA
    Biol Psychiatry; 2024 Oct; ():. PubMed ID: 39395473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
    Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA
    Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
    Martinez D; Slifstein M; Broft A; Mawlawi O; Hwang DR; Huang Y; Cooper T; Kegeles L; Zarahn E; Abi-Dargham A; Haber SN; Laruelle M
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):285-300. PubMed ID: 12621304
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors.
    Hwang DR; Narendran R; Laruelle M
    Bioconjug Chem; 2005; 16(1):27-31. PubMed ID: 15656572
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
    Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.